SGTX
Sigilon Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
Company Profile
CEO
Rogerio Vivaldi Coelho MBA
IPO Date
2020-12-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Sigilon Therapeutics, Inc.
CEO
Rogerio Vivaldi Coelho MBA
IPO Date
2020-12-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 1,718,493 |
| $14.92 |
| 11 Aug 2023 | Kowalsky Matthew Paul | CHIEF OF STAFF AND CLO | D-Return | Disposed | 1,925 | $14.92 |
| 11 Aug 2023 | Kowalsky Matthew Paul | CHIEF OF STAFF AND CLO | D-Return | Disposed | 12,690 | $14.17 |
| 11 Aug 2023 | RUFFOLO ROBERT R | director | D-Return | Disposed | 683 | $8.28 |
| 11 Aug 2023 | RUFFOLO ROBERT R | director | D-Return | Disposed | 683 | $9.92 |
| 11 Aug 2023 | RUFFOLO ROBERT R | director | D-Return | Disposed | 3,754 | $7.41 |
| 11 Aug 2023 | Cole Douglas G. | director | D-Return | Disposed | 683 | $8.28 |
| 11 Aug 2023 | Cole Douglas G. | director | D-Return | Disposed | 683 | $9.92 |
| 11 Aug 2023 | Cox John | director | D-Return | Disposed | 341 | $14.92 |